1
|
Ahmed MIM, Plank M, Castelletti N, Diepers P, Eser TM, Rubio-Acero R, Noreña I, Reinkemeyer C, Zapf D, Hoelscher M, Janke C, Wieser A, Geldmacher C. Impact of Omicron Variant Infection on Assessment of Spike-Specific Immune Responses Using the EUROIMMUN Quan-T-Cell SARS-CoV-2 Assay and Roche Elecsys Anti-SARS-CoV-2-S. Diagnostics (Basel) 2023; 13:diagnostics13061024. [PMID: 36980332 PMCID: PMC10047097 DOI: 10.3390/diagnostics13061024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2023] [Revised: 03/01/2023] [Accepted: 03/06/2023] [Indexed: 03/30/2023] Open
Abstract
The currently prevailing variants of SARS-CoV-2 are subvariants of the Omicron variant. The aim of this study was to analyze the effect of mutations in the Spike protein of Omicron on the results Quan-T-Cell SARS-CoV-2 assays and Roche Elecsys anti-SARS-CoV-2 anti-S1. Omicron infected subjects ((n = 37), vaccinated (n = 20) and unvaccinated (n = 17)) were recruited approximately 3 weeks after a positive PCR test. The Quan-T-Cell SARS-CoV-2 assays (EUROIMMUN) using Wuhan and the Omicron adapted antigen assay and a serological test (Roche Elecsys anti-SARS-CoV-2 anti-S1) were performed. Using the original Wuhan SARS-CoV-2 IGRA TUBE, in 19 of 21 tested Omicron infected subjects, a positive IFNy response was detected, while 2 non-vaccinated but infected subjects did not respond. The Omicron adapted antigen tube resulted in comparable results. In contrast, the serological assay detected a factor 100-fold lower median Spike-specific RBD antibody concentration in non-vaccinated Omicron infected patients (n = 12) compared to patients from the pre Omicron era (n = 12) at matched time points, and eight individuals remained below the detection threshold for positivity. For vaccinated subjects, the Roche assay detected antibodies in all subjects and showed a 400 times higher median specific antibody concentration compared to non-vaccinated infected subjects in the pre-Omicron era. Our results suggest that Omicron antigen adapted IGRA stimulator tubes did not improve detection of SARS-CoV-2-specific T-cell responses in the Quant-T-Cell-SARS-CoV-2 assay. In non-vaccinated Omicron infected individuals, the Wuhan based Elecsys anti-SARS-CoV-2 anti-S1 serological assay results in many negative results at 3 weeks after diagnosis.
Collapse
Affiliation(s)
- Mohamed I M Ahmed
- Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
- German Center for Infection Research (DZIF), Partner Site Munich, 81675 Munich, Germany
| | - Michael Plank
- Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
| | - Noemi Castelletti
- Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
- Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology, Infection and Pandemic Research, 80799 Munich, Germany
- Institute of Radiation Medicine, Helmholtz Munich, German Research Centre for Environmental Health, 85764 Neuherberg, Germany
| | - Paulina Diepers
- Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
| | - Tabea M Eser
- Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
- German Center for Infection Research (DZIF), Partner Site Munich, 81675 Munich, Germany
| | - Raquel Rubio-Acero
- Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
| | - Ivan Noreña
- Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
| | - Christina Reinkemeyer
- Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
| | - Dorinja Zapf
- Institute for Experimental Immunology, Affiliated to EUROIMMUN Medizinische Labordiagnostika AG, 23560 Lübeck, Germany
| | - Michael Hoelscher
- Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
- German Center for Infection Research (DZIF), Partner Site Munich, 81675 Munich, Germany
- Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology, Infection and Pandemic Research, 80799 Munich, Germany
| | - Christian Janke
- Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
| | - Andreas Wieser
- Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
- German Center for Infection Research (DZIF), Partner Site Munich, 81675 Munich, Germany
- Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology, Infection and Pandemic Research, 80799 Munich, Germany
- Max Von Pettenkofer Institute, Faculty of Medicine, LMU Munich, 80336 Munich, Germany
| | - Christof Geldmacher
- Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
- German Center for Infection Research (DZIF), Partner Site Munich, 81675 Munich, Germany
- Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology, Infection and Pandemic Research, 80799 Munich, Germany
| |
Collapse
|
2
|
Calcoen B, Callewaert N, Vandenbulcke A, Kerstens W, Imbrechts M, Vercruysse T, Dallmeier K, Van Weyenbergh J, Maes P, Bossuyt X, Zapf D, Dieckmann K, Callebaut K, Thibaut HJ, Vanhoorelbeke K, De Meyer SF, Maes W, Geukens N. High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in Belgium. Viruses 2022; 14:1257. [PMID: 35746728 PMCID: PMC9228150 DOI: 10.3390/v14061257] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2022] [Revised: 05/30/2022] [Accepted: 05/31/2022] [Indexed: 11/26/2022] Open
Abstract
To mitigate the massive COVID-19 burden caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), several vaccination campaigns were initiated. We performed a single-center observational trial to monitor the mid- (3 months) and long-term (10 months) adaptive immune response and to document breakthrough infections (BTI) in healthcare workers (n = 84) upon BNT162b2 vaccination in a real-world setting. Firstly, serology was determined through immunoassays. Secondly, antibody functionality was analyzed via in vitro binding inhibition and pseudovirus neutralization and circulating receptor-binding domain (RBD)-specific B cells were assessed. Moreover, the induction of SARS-CoV-2-specific T cells was investigated by an interferon-γ release assay combined with flowcytometric profiling of activated CD4+ and CD8+ T cells. Within individuals that did not experience BTI (n = 62), vaccine-induced humoral and cellular immune responses were not correlated. Interestingly, waning over time was more pronounced within humoral compared to cellular immunity. In particular, 45 of these 62 subjects no longer displayed functional neutralization against the delta variant of concern (VoC) at long-term follow-up. Noteworthily, we reported a high incidence of symptomatic BTI cases (17.11%) caused by alpha and delta VoCs, although vaccine-induced immunity was only slightly reduced compared to subjects without BTI at mid-term follow-up.
Collapse
Affiliation(s)
- Bas Calcoen
- Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, 8500 Kortrijk, Belgium; (B.C.); (A.V.); (K.V.); (S.F.D.M.)
| | - Nico Callewaert
- AZ Groeninge Hospital, Department of Laboratory Medicine, 8500 Kortrijk, Belgium; (K.C.); (N.C.)
| | - Aline Vandenbulcke
- Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, 8500 Kortrijk, Belgium; (B.C.); (A.V.); (K.V.); (S.F.D.M.)
| | - Winnie Kerstens
- Laboratory of Virology and Chemotherapy, Translational Platform Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, KU Leuven Rega Institute, 3000 Leuven, Belgium; (W.K.); (T.V.); (H.J.T.)
| | - Maya Imbrechts
- PharmAbs, the KU Leuven Antibody Center, KU Leuven, 3000 Leuven, Belgium; (M.I.); (N.G.)
| | - Thomas Vercruysse
- Laboratory of Virology and Chemotherapy, Translational Platform Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, KU Leuven Rega Institute, 3000 Leuven, Belgium; (W.K.); (T.V.); (H.J.T.)
| | - Kai Dallmeier
- Laboratory of Virology, Molecular Vaccinology and Vaccine Discovery, Department of Microbiology, Immunology and Transplantation, KU Leuven Rega Institute, 3000 Leuven, Belgium;
| | - Johan Van Weyenbergh
- Laboratory for Clinical and Epidemiological Virology, KU Leuven Rega Institute, 3000 Leuven, Belgium; (J.V.W.); (P.M.)
| | - Piet Maes
- Laboratory for Clinical and Epidemiological Virology, KU Leuven Rega Institute, 3000 Leuven, Belgium; (J.V.W.); (P.M.)
| | - Xavier Bossuyt
- Department of Microbiology, Immunology and Transplantation, KU Leuven, 3000 Leuven, Belgium;
- Department of Laboratory Medicine, University Hospitals Leuven, 3000 Leuven, Belgium
| | - Dorinja Zapf
- Institut für Experimentelle Immunologie, EUROIMMUN Medizinische Labordiagnostika AG, 23552 Lübeck, Germany; (D.Z.); (K.D.)
| | - Kersten Dieckmann
- Institut für Experimentelle Immunologie, EUROIMMUN Medizinische Labordiagnostika AG, 23552 Lübeck, Germany; (D.Z.); (K.D.)
| | - Kim Callebaut
- AZ Groeninge Hospital, Department of Laboratory Medicine, 8500 Kortrijk, Belgium; (K.C.); (N.C.)
| | - Hendrik Jan Thibaut
- Laboratory of Virology and Chemotherapy, Translational Platform Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, KU Leuven Rega Institute, 3000 Leuven, Belgium; (W.K.); (T.V.); (H.J.T.)
| | - Karen Vanhoorelbeke
- Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, 8500 Kortrijk, Belgium; (B.C.); (A.V.); (K.V.); (S.F.D.M.)
- PharmAbs, the KU Leuven Antibody Center, KU Leuven, 3000 Leuven, Belgium; (M.I.); (N.G.)
| | - Simon F. De Meyer
- Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, 8500 Kortrijk, Belgium; (B.C.); (A.V.); (K.V.); (S.F.D.M.)
| | - Wim Maes
- PharmAbs, the KU Leuven Antibody Center, KU Leuven, 3000 Leuven, Belgium; (M.I.); (N.G.)
| | - Nick Geukens
- PharmAbs, the KU Leuven Antibody Center, KU Leuven, 3000 Leuven, Belgium; (M.I.); (N.G.)
| |
Collapse
|
3
|
Markewitz R, Pauli D, Dargvainiene J, Steinhagen K, Engel S, Herbst V, Zapf D, Krüger C, Sharifzadeh S, Schomburg B, Leypoldt F, Rupp J, Görg S, Junker R, Wandinger KP. The temporal course of T- and B-cell responses to vaccination with BNT162b2 and mRNA-1273. Clin Microbiol Infect 2022; 28:701-709. [PMID: 34547457 PMCID: PMC8450229 DOI: 10.1016/j.cmi.2021.09.006] [Citation(s) in RCA: 15] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2021] [Revised: 08/31/2021] [Accepted: 09/05/2021] [Indexed: 12/29/2022]
Abstract
OBJECTIVES To investigate the response of the immune system (and its influencing factors) to vaccination with BNT162b2 or mRNA-1273. METHODS 531 vaccinees, recruited from healthcare professionals, donated samples before, in between, and after the administration of the two doses of the vaccine. T- and B-cell responses were examined via interferon-γ (IFN-γ) release assay, and antibodies against different epitopes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (S1 and NCP) were detected via ELISA and surrogate neutralization assay. Results were correlated with influencing factors such as age, sex, prior infection, vaccine received (BNT162b2 or mRNA-1273), and immunosuppression. Furthermore, antinuclear antibodies (ANAs) were measured to screen for autoimmune responses following vaccination with an mRNA vaccine. RESULTS No markers of immunity against SARS-CoV-2 were found before the first vaccination. Two weeks after it, specific responses against SARS-CoV-2 were already measurable (median ± median absolute deviation (MAD): anti-S1 IgG 195.5 ± 172.7 BAU/mL; IgA 6.7 ± 4.9 OD; surrogate neutralization 39 ± 23.7%), and were significantly increased two weeks after the second dose (anti-S1 IgG 3744 ± 2571.4 BAU/mL; IgA 12 ± 0 OD; surrogate neutralization 100 ± 0%, IFN-γ 1897.2 ± 886.7 mIU/mL). Responses were stronger for younger participants (this difference decreasing after the second dose). Further influences were previous infection with SARS-CoV-2 (causing significantly stronger responses after the first dose compared to unexposed individuals (p ≤ 0.0001)) and the vaccine received (significantly stronger reactions for recipients of mRNA-1273 after both doses, p < 0.05-0.0001). Some forms of immunosuppression significantly impeded the immune response to the vaccination (with no observable immune response in three immunosuppressed participants). There was no significant induction of ANAs by the vaccination (no change in qualitative ANA results (p 0.2592) nor ANA titres (p 0.08) from pre-to post-vaccination. CONCLUSIONS Both vaccines elicit strong and specific immune responses against SARS-CoV-2 which become detectable one week (T-cell response) or two weeks (B-cell response) after the first dose.
Collapse
Affiliation(s)
- Robert Markewitz
- Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Kiel, Germany.
| | - Daniela Pauli
- Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Kiel, Germany
| | - Justina Dargvainiene
- Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Kiel, Germany
| | - Katja Steinhagen
- Institute for Experimental Immunology, EUROIMMUN AG, Lübeck, Germany
| | - Sarah Engel
- Department of Anesthesiology and Intensive Care, University Hospital of Schleswig-Holstein Campus Lübeck, Lübeck, Germany
| | - Victor Herbst
- Institute for Experimental Immunology, EUROIMMUN AG, Lübeck, Germany
| | - Dorinja Zapf
- Institute for Experimental Immunology, EUROIMMUN AG, Lübeck, Germany
| | - Christina Krüger
- Institute for Experimental Immunology, EUROIMMUN AG, Lübeck, Germany
| | - Shahpour Sharifzadeh
- Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Kiel, Germany
| | - Benjamin Schomburg
- Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Kiel, Germany
| | - Frank Leypoldt
- Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Kiel, Germany; Department of Neurology, University Hospital Schleswig-Holstein, Kiel, Germany
| | - Jan Rupp
- Department of Infectious Diseases and Microbiology, University of Lübeck, Lübeck, Germany
| | - Siegfried Görg
- Institute of Transfusion Medicine, University Hospital of Schleswig-Holstein, Lübeck, Germany
| | - Ralf Junker
- Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Kiel, Germany
| | - Klaus-Peter Wandinger
- Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Kiel, Germany
| |
Collapse
|
4
|
Zapf D, Kantelhardt J, Köhler W. Nonlinearities in shadowgraphy experiments on non-equilibrium fluctuations in polymer solutions. Eur Phys J E Soft Matter 2022; 45:40. [PMID: 35471468 PMCID: PMC9043008 DOI: 10.1140/epje/s10189-022-00195-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 02/18/2022] [Accepted: 04/11/2022] [Indexed: 06/14/2023]
Abstract
Giant thermal and solutal non-equilibrium fluctuations are observed in shadowgraphy experiments on liquid mixtures subjected to a temperature gradient. For large temperature differences, both the temperature and the composition dependence of the relevant thermophysical parameters and the nonlinear terms in the diffusion equation need to be taken into account, leading to a nonlinear concentration profile. For temperature differences exceeding the inverse of the Soret coefficient, in our example approximately 10 K, the usual data evaluation yields increasingly wrong diffusion and Soret coefficients that are off by almost a factor of two for a temperature difference of 50 K. A local model that treats the measured shadowgraph signal as a superposition of the contributions from every layer of the sample is able to capture the essential trend and yields a good agreement with experimental data. The results are important for the application of shadowgraphy as a tool for the measurement of Soret and diffusion coefficients, where large temperature gradients promise a good signal-to-noise ratio.
Collapse
Affiliation(s)
- D Zapf
- Physikalisches Institut, Universität Bayreuth, 95440, Bayreuth, Germany
| | - J Kantelhardt
- Physikalisches Institut, Universität Bayreuth, 95440, Bayreuth, Germany
| | - W Köhler
- Physikalisches Institut, Universität Bayreuth, 95440, Bayreuth, Germany.
| |
Collapse
|
5
|
Markewitz RDH, Juhl D, Pauli D, Görg S, Junker R, Rupp J, Engel S, Steinhagen K, Herbst V, Zapf D, Krüger C, Brockmann C, Leypoldt F, Dargvainiene J, Schomburg B, Sharifzadeh SR, Salek Nejad L, Wandinger KP, Ziemann M. Differences in Immunogenicity of Three Different Homo- and Heterologous Vaccination Regimens against SARS-CoV-2. Vaccines (Basel) 2022; 10:vaccines10050649. [PMID: 35632405 PMCID: PMC9145236 DOI: 10.3390/vaccines10050649] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2022] [Revised: 04/15/2022] [Accepted: 04/18/2022] [Indexed: 12/10/2022] Open
Abstract
Background: Due to findings on adverse reactions and clinical efficacy of different vaccinations against SARS-CoV-2, the administration of vaccination regimens containing both adenoviral vector vaccines and mRNA-based vaccines has become common. Data are still needed on the direct comparison of immunogenicity for these different regimens. Methods: We compared markers for immunogenicity (anti-S1 IgG/IgA, neutralizing antibodies, and T-cell response) with three different vaccination regimens (homologous ChAdOx1 nCoV-19 (n = 103), or mixture of ChAdOx1 nCoV-19 with mRNA-1273 (n = 116) or BNT162b2 (n = 105)) at two time points: the day of the second vaccination as a baseline and 14 days later. Results: All examined vaccination regimens elicited measurable immune responses that were significantly enhanced after the second dose. Homologous ChAdOx1 nCoV-19 was markedly inferior in immunogenicity to all other examined regimens after administration of the second dose. Between the heterologous regimens, mRNA-1273 as second dose induced greater antibody responses than BNT162b2, with no difference found for neutralizing antibodies and T-cell response. Discussion: While these findings allow no prediction about clinical protection, from an immunological point of view, vaccination against SARS-CoV-2 with an mRNA-based vaccine at one or both time points appears preferable to homologous vaccination with ChAdOx1 nCoV-19. Whether or not the demonstrated differences between the heterologous regimens are of clinical significance will be subject to further research.
Collapse
Affiliation(s)
- Robert Daniel Heinrich Markewitz
- Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany; (D.P.); (R.J.); (F.L.); (J.D.); (B.S.); (S.R.S.); (L.S.N.); (K.-P.W.)
- Correspondence: ; Tel.: +49-451-00-16315
| | - David Juhl
- Institute for Transfusion Medicine, University Hospital of Schleswig-Holstein, 23538 Lübeck, Germany; (D.J.); (S.G.); (C.B.); (M.Z.)
| | - Daniela Pauli
- Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany; (D.P.); (R.J.); (F.L.); (J.D.); (B.S.); (S.R.S.); (L.S.N.); (K.-P.W.)
| | - Siegfried Görg
- Institute for Transfusion Medicine, University Hospital of Schleswig-Holstein, 23538 Lübeck, Germany; (D.J.); (S.G.); (C.B.); (M.Z.)
| | - Ralf Junker
- Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany; (D.P.); (R.J.); (F.L.); (J.D.); (B.S.); (S.R.S.); (L.S.N.); (K.-P.W.)
| | - Jan Rupp
- Department of Infectious Diseases and Microbiology, University of Lübeck, 23538 Lübeck, Germany;
| | - Sarah Engel
- Department of Anesthesiology and Intensive Care, University Hospital of Schleswig-Holstein Campus Lübeck, 23562 Lübeck, Germany;
| | - Katja Steinhagen
- Institute for Experimental Immunology, EUROIMMUN AG, 23560 Lübeck, Germany; (K.S.); (V.H.); (D.Z.); (C.K.)
| | - Victor Herbst
- Institute for Experimental Immunology, EUROIMMUN AG, 23560 Lübeck, Germany; (K.S.); (V.H.); (D.Z.); (C.K.)
| | - Dorinja Zapf
- Institute for Experimental Immunology, EUROIMMUN AG, 23560 Lübeck, Germany; (K.S.); (V.H.); (D.Z.); (C.K.)
| | - Christina Krüger
- Institute for Experimental Immunology, EUROIMMUN AG, 23560 Lübeck, Germany; (K.S.); (V.H.); (D.Z.); (C.K.)
| | - Christian Brockmann
- Institute for Transfusion Medicine, University Hospital of Schleswig-Holstein, 23538 Lübeck, Germany; (D.J.); (S.G.); (C.B.); (M.Z.)
| | - Frank Leypoldt
- Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany; (D.P.); (R.J.); (F.L.); (J.D.); (B.S.); (S.R.S.); (L.S.N.); (K.-P.W.)
| | - Justina Dargvainiene
- Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany; (D.P.); (R.J.); (F.L.); (J.D.); (B.S.); (S.R.S.); (L.S.N.); (K.-P.W.)
| | - Benjamin Schomburg
- Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany; (D.P.); (R.J.); (F.L.); (J.D.); (B.S.); (S.R.S.); (L.S.N.); (K.-P.W.)
| | - Shahpour Reza Sharifzadeh
- Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany; (D.P.); (R.J.); (F.L.); (J.D.); (B.S.); (S.R.S.); (L.S.N.); (K.-P.W.)
| | - Lukas Salek Nejad
- Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany; (D.P.); (R.J.); (F.L.); (J.D.); (B.S.); (S.R.S.); (L.S.N.); (K.-P.W.)
| | - Klaus-Peter Wandinger
- Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany; (D.P.); (R.J.); (F.L.); (J.D.); (B.S.); (S.R.S.); (L.S.N.); (K.-P.W.)
| | - Malte Ziemann
- Institute for Transfusion Medicine, University Hospital of Schleswig-Holstein, 23538 Lübeck, Germany; (D.J.); (S.G.); (C.B.); (M.Z.)
| |
Collapse
|
6
|
Markewitz R, Pauli D, Dargvainiene J, Steinhagen K, Engel S, Herbst V, Zapf D, Krüger C, Sharifzadeh S, Schomburg B, Leypoldt F, Rupp J, Görg S, Junker R, Wandinger KP. B-cell-responses to vaccination with BNT162b2 and mRNA-1273 six months after second dose. Clin Microbiol Infect 2022; 28:1024.e1-1024.e6. [PMID: 35259531 PMCID: PMC8897957 DOI: 10.1016/j.cmi.2022.02.028] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2021] [Revised: 02/02/2022] [Accepted: 02/27/2022] [Indexed: 12/19/2022]
Abstract
Objectives To examine the state of B-cell immunity 6 months after the second vaccination against SARS-CoV-2 in comparison to the state observed 2 weeks after vaccination. Methods Sera of 439 participants, whose immune responses to two doses of an mRNA-based vaccine (BNT162b2 or mRNA-1273) were previously characterized, was examined for anti-S1 IgG and IgA, anti-NCP IgG and neutralizing antibodies (nAb), and antinuclear antibodies (ANA). Results Levels of all examined markers decreased significantly from 2 weeks to 6 months after second vaccination (anti-S1 IgG: 3744 ± 2571.4 vs. 253 ± 144 binding antibody units (BAU)/mL; anti-S1 IgA: 12 ± 0 vs. 1.98 ± 1.75 optical density (OD) ratio; nAb: 100% ± 0% vs. 82% ± 19.3%), the vast majority of participants retaining reactive levels of anti-S1 IgG (436/439) and anti-S1 IgA (334/439) at 6 months. Immune responses were stronger for mRNA-1273 compared with BNT162b2 (anti-S1 IgG: 429 ± 289 vs. 243 ± 143 BAU/mL; anti-S1 IgA: 5.38 ± 3.91 vs. 1.89 ± 1.53 OD ratio; nAb: 90.5% ± 12.6% vs. 81% ± 19.3%). There was no meaningful influence of sex and age on the examined markers. There was a strong correlation between anti-S1 IgG and the surrogate neutralization assay (rho = 0.91, p <0.0001), but not for for IgA and the surrogate neutralization assay (rho = 0.52, p <0.0001). There was a ceiling effect for the association between anti-S1 IgG titres and the inhibition of binding between S1 and ACE2. ANA prevalence was unchanged from 2 weeks to 6 months after the second vaccination (87/498 vs. 77/435), as were the median ANA titres (1:160 vs. 1:160). Discussion Although the clinical consequences of decreasing anti-SARS-CoV-2 antibody titres cannot be estimated with certainty, a lowered degree of clinical protection against SARS-CoV-2 is possible. Persistently stronger responses to mRNA-1273 suggest that it might confer greater protection than BNT162b2, even 6 months after the second vaccination. Neither examined vaccinations induced ANA within the examined time frame.
Collapse
|
7
|
Markewitz R, Juhl D, Pauli D, Görg S, Junker R, Rupp J, Engel S, Steinhagen K, Herbst V, Zapf D, Krüger C, Brockmann C, Leypoldt F, Dargvainiene J, Schomburg B, Sharifzadeh S, Nejad LS, Wandinger KP, Ziemann M. Kinetics of the Antibody Response to Boostering With Three Different Vaccines Against SARS-CoV-2. Front Immunol 2022; 13:811020. [PMID: 35126395 PMCID: PMC8807650 DOI: 10.3389/fimmu.2022.811020] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2021] [Accepted: 01/03/2022] [Indexed: 12/14/2022] Open
Abstract
BackgroundHeterologous vaccinations against SARS-CoV-2 with ChAdOx1 nCoV-19 and a second dose of an mRNA-based vaccine have been shown to be more immunogenic than homologous ChAdOx1 nCoV-19. In the current study, we examined the kinetics of the antibody response to the second dose of three different vaccination regimens (homologous ChAdOx1 nCoV-19 vs. ChAdOx1 nCoV-19 + BNT162b2 or mRNA-1273) against SARS-CoV-2 in a longitudinal manner; whether there are differences in latency or amplitude of the early response and which markers are most suitable to detect these responses.MethodsWe performed assays for anti-S1 IgG and IgA, anti-NCP IgG and a surrogate neutralization assay on serum samples collected from 57 participants on the day of the second vaccination as well as the following seven days.ResultsAll examined vaccination regimens induced detectable antibody responses within the examined time frame. Both heterologous regimens induced responses earlier and with a higher amplitude than homologous ChAdOx1 nCoV-19. Between the heterologous regimens, amplitudes were somewhat higher for ChAdOx1 nCoV-19 + mRNA-1273. There was no difference in latency between the IgG and IgA responses. Increases in the surrogate neutralization assay were the first changes to be detectable for all regimens and the only significant change seen for homologous ChAdOx1 nCoV-19.DiscussionBoth examined heterologous vaccination regimens are superior in immunogenicity, including the latency of the response, to homologous ChAdOx1 nCoV-19. While the IgA response has a shorter latency than the IgG response after the first dose, no such difference was found after the second dose, implying that both responses are driven by separate plasma cell populations. Early and steep increases in surrogate neutralization levels suggest that this might be a more sensitive marker for antibody responses after vaccination against SARS-CoV-2 than absolute levels of anti-S1 IgG.
Collapse
Affiliation(s)
- Robert Markewitz
- Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Kiel, Germany
- *Correspondence: Robert Markewitz,
| | - David Juhl
- Institute of Transfusion Medicine, University Hospital of Schleswig-Holstein, Lübeck, Germany
| | - Daniela Pauli
- Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Kiel, Germany
| | - Siegfried Görg
- Institute of Transfusion Medicine, University Hospital of Schleswig-Holstein, Lübeck, Germany
| | - Ralf Junker
- Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Kiel, Germany
| | - Jan Rupp
- Department of Infectious Diseases and Microbiology, University of Lübeck, Lübeck, Germany
| | - Sarah Engel
- Department of Anesthesiology and Intensive Care, University Hospital of Schleswig-Holstein, Lübeck, Germany
| | - Katja Steinhagen
- Institute for Experimental Immunology, EUROIMMUN AG, Lübeck, Germany
| | - Victor Herbst
- Institute for Experimental Immunology, EUROIMMUN AG, Lübeck, Germany
| | - Dorinja Zapf
- Institute for Experimental Immunology, EUROIMMUN AG, Lübeck, Germany
| | - Christina Krüger
- Institute for Experimental Immunology, EUROIMMUN AG, Lübeck, Germany
| | - Christian Brockmann
- Institute of Transfusion Medicine, University Hospital of Schleswig-Holstein, Lübeck, Germany
| | - Frank Leypoldt
- Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Kiel, Germany
| | - Justina Dargvainiene
- Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Kiel, Germany
| | - Benjamin Schomburg
- Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Kiel, Germany
| | - Shahpour Sharifzadeh
- Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Kiel, Germany
| | - Lukas Salek Nejad
- Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Kiel, Germany
| | - Klaus-Peter Wandinger
- Institute of Clinical Chemistry, University Hospital of Schleswig-Holstein, Kiel, Germany
| | - Malte Ziemann
- Institute of Transfusion Medicine, University Hospital of Schleswig-Holstein, Lübeck, Germany
| |
Collapse
|
8
|
Schiffner J, Backhaus I, Rimmele J, Schulz S, Möhlenkamp T, Klemens JM, Zapf D, Solbach W, Mischnik A. Long-Term Course of Humoral and Cellular Immune Responses in Outpatients After SARS-CoV-2 Infection. Front Public Health 2021; 9:732787. [PMID: 34646805 PMCID: PMC8502872 DOI: 10.3389/fpubh.2021.732787] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2021] [Accepted: 08/25/2021] [Indexed: 12/24/2022] Open
Abstract
Characterization of the naturally acquired B and T cell immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is important for the development of public health and vaccination strategies to manage the burden of COVID-19 disease. We conducted a prospective, cross-sectional analysis in COVID-19 recovered patients at various time points over a 10-month period in order to investigate how circulating antibody levels and interferon-gamma (IFN-γ) release by peripheral blood cells change over time following natural infection. From March 2020 till January 2021, we enrolled 412 adults mostly with mild or moderate disease course. At each study visit, subjects donated peripheral blood for testing of anti-SARS-CoV-2 IgG antibodies and IFN-γ release after SARS-CoV-2 S-protein stimulation. Anti-SARS-CoV-2 immunoglobulin G (IgG) antibodies were positive in 316 of 412 (76.7%) and borderline in 31 of 412 (7.5%) patients. Our confirmation assay for the presence of neutralizing antibodies was positive in 215 of 412 (52.2%) and borderline in 88 of 412 (21.4%) patients. Likewise, in 274 of 412 (66.5%) positive IFN-γ release and IgG antibodies were detected. With respect to time after infection, both IgG antibody levels and IFN-γ concentrations decreased by about half within 300 days. Statistically, production of IgG and IFN-γ were closely associated, but on an individual basis, we observed patients with high-antibody titres but low IFN-γ levels and vice versa. Our data suggest that immunological reaction is acquired in most individuals after natural infection with SARS-CoV-2 and is sustained in the majority of patients for at least 10 months after infection after a mild or moderate disease course. Since, so far, no robust marker for protection against COVID-19 exists, we recommend utilizing both, IgG and IFN-γ release for an individual assessment of the immunity status.
Collapse
Affiliation(s)
- Julia Schiffner
- Center for Infection and Inflammation Research, University of Luebeck, Luebeck, Germany.,German Center for Infection Research (DZIF), Standort Hamburg-Borstel-Luebeck-Riems, Luebeck, Germany.,Health Protection Authority, Luebeck, Germany
| | - Insa Backhaus
- Medical Faculty, Centre for Health and Society, University Hospital, Institute of Medical Sociology, Heinrich-Heine-University, Düsseldorf, Germany
| | | | | | | | - Julia Maria Klemens
- Institute for Experimental Immunology, Affiliated to EUROIMMUN Medizinische Labordiagnostika AG, Luebeck, Germany
| | - Dorinja Zapf
- Institute for Experimental Immunology, Affiliated to EUROIMMUN Medizinische Labordiagnostika AG, Luebeck, Germany
| | - Werner Solbach
- Center for Infection and Inflammation Research, University of Luebeck, Luebeck, Germany.,German Center for Infection Research (DZIF), Standort Hamburg-Borstel-Luebeck-Riems, Luebeck, Germany.,Health Protection Authority, Luebeck, Germany
| | | |
Collapse
|
9
|
Abstract
We have performed shadowgraphy experiments on a dilute polymer solution subjected to a temperature gradient in order to investigate simultaneous thermal and solutal non-equilibrium fluctuations (NEFs). The gravitational quenching of the NEFs at small q-vectors defines the thermal and solutal roll-off wavevectors, which can be extracted from both the static structure function and the time correlation functions. Both methods yield good agreement, and the ∼10% larger static solutal roll-off wavevector coincides with a similar observation reported in the literature. The thermal diffusivity of the solution and the diffusion, thermodiffusion, and Soret coefficients of the polymer can be obtained from the q-dependence of the relaxation times and from the thermal and solutal roll-off wavevectors without explicit knowledge of the optical contrast factors. This provides an alternative route for the measurement of diffusive transport coefficients, albeit with an unfavorable error propagation.
Collapse
Affiliation(s)
- D Zapf
- Physikalisches Institut, Universität Bayreuth, D-95440 Bayreuth, Germany
| | - W Köhler
- Physikalisches Institut, Universität Bayreuth, D-95440 Bayreuth, Germany
| |
Collapse
|
10
|
Braibanti M, Artola PA, Baaske P, Bataller H, Bazile JP, Bou-Ali MM, Cannell DS, Carpineti M, Cerbino R, Croccolo F, Diaz J, Donev A, Errarte A, Ezquerro JM, Frutos-Pastor A, Galand Q, Galliero G, Gaponenko Y, García-Fernández L, Gavaldá J, Giavazzi F, Giglio M, Giraudet C, Hoang H, Kufner E, Köhler W, Lapeira E, Laverón-Simavilla A, Legros JC, Lizarraga I, Lyubimova T, Mazzoni S, Melville N, Mialdun A, Minster O, Montel F, Molster FJ, Ortiz de Zárate JM, Rodríguez J, Rousseau B, Ruiz X, Ryzhkov II, Schraml M, Shevtsova V, Takacs CJ, Triller T, Van Vaerenbergh S, Vailati A, Verga A, Vermorel R, Vesovic V, Yasnou V, Xu S, Zapf D, Zhang K. European Space Agency experiments on thermodiffusion of fluid mixtures in space. Eur Phys J E Soft Matter 2019; 42:86. [PMID: 31289962 DOI: 10.1140/epje/i2019-11849-0] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/21/2019] [Accepted: 06/05/2019] [Indexed: 06/09/2023]
Abstract
This paper describes the European Space Agency (ESA) experiments devoted to study thermodiffusion of fluid mixtures in microgravity environment, where sedimentation and convection do not affect the mass flow induced by the Soret effect. First, the experiments performed on binary mixtures in the IVIDIL and GRADFLEX experiments are described. Then, further experiments on ternary mixtures and complex fluids performed in DCMIX and planned to be performed in the context of the NEUF-DIX project are presented. Finally, multi-component mixtures studied in the SCCO project are detailed.
Collapse
Affiliation(s)
- M Braibanti
- European Space Agency (ESA), ESTEC, Noordwijk, The Netherlands.
| | - P -A Artola
- Laboratoire de Chimie-Physique, UMR 8000 CNRS, Université Paris-Sud, Orsay, France
| | - P Baaske
- Nanotemper Technologies GmbH, Munich, Germany
| | - H Bataller
- Laboratoire des Fluides Complexes et leurs Réservoirs - IPRA, UMR5150, E2S-Univ Pau & Pays Adour / CNRS / TOTAL, 1 Allée du Parc Montaury, 64600, Anglet, France
| | - J -P Bazile
- Laboratoire des Fluides Complexes et leurs Réservoirs - IPRA, UMR5150, E2S-Univ Pau & Pays Adour / CNRS / TOTAL, 64000, Pau, France
| | - M M Bou-Ali
- MGEP Mondragon GoiEskola Politeknikoa, Mechanical and Industrial Manufacturing Department, Mondragon, Spain
| | - D S Cannell
- Department of Physics, University of California at Santa Barbara, 93106, Santa Barbara, CA, USA
| | - M Carpineti
- Dipartimento di Fisica, Università degli Studi di Milano, I-20133, Milano, Italy
| | - R Cerbino
- Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, 20090, Segrate, Italy
| | - F Croccolo
- Laboratoire des Fluides Complexes et leurs Réservoirs - IPRA, UMR5150, E2S-Univ Pau & Pays Adour / CNRS / TOTAL, 1 Allée du Parc Montaury, 64600, Anglet, France
| | - J Diaz
- Laboratoire des Fluides Complexes et leurs Réservoirs - IPRA, UMR5150, E2S-Univ Pau & Pays Adour / CNRS / TOTAL, 64000, Pau, France
| | - A Donev
- Courant Institute of Mathematical Sciences, New York University, 10012, New York, NY, USA
| | - A Errarte
- MGEP Mondragon GoiEskola Politeknikoa, Mechanical and Industrial Manufacturing Department, Mondragon, Spain
| | - J M Ezquerro
- E-USOC. ETSIAE, Universidad Politécnica de Madrid, Madrid, Spain
| | - A Frutos-Pastor
- European Space Agency (ESA), ESTEC, Noordwijk, The Netherlands
| | - Q Galand
- MRC, Université libre de Bruxelles, Av. F.D. Roosevelt, 50, CP165/62, 1050, Brussels, Belgium
| | - G Galliero
- Laboratoire des Fluides Complexes et leurs Réservoirs - IPRA, UMR5150, E2S-Univ Pau & Pays Adour / CNRS / TOTAL, 64000, Pau, France
| | - Y Gaponenko
- MRC, Université libre de Bruxelles, Av. F.D. Roosevelt, 50, CP165/62, 1050, Brussels, Belgium
| | - L García-Fernández
- Laboratoire des Fluides Complexes et leurs Réservoirs - IPRA, UMR5150, E2S-Univ Pau & Pays Adour / CNRS / TOTAL, 1 Allée du Parc Montaury, 64600, Anglet, France
- Centre National d'Etudes Spatiales (CNES), 2, Place Maurice Quentin, 75001, Paris, France
| | - J Gavaldá
- Departament de Química Física i Inòrganica, Universitat Rovira i Virgili, Tarragona, Spain
| | - F Giavazzi
- Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, 20090, Segrate, Italy
| | - M Giglio
- Dipartimento di Fisica, Università degli Studi di Milano, I-20133, Milano, Italy
| | - C Giraudet
- Erlangen Graduate School in Advanced Optical Technologies (SAOT), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany
| | - H Hoang
- Institute of Fundamental and Applied Sciences, Duy Tan University, 10C Tran Nhat Duat Street, District 1, 700000, Ho Chi Minh City, Vietnam
| | - E Kufner
- European Space Agency (ESA), ESTEC, Noordwijk, The Netherlands
| | - W Köhler
- Physikalisches Institut, Universität Bayreuth, D-95440, Bayreuth, Germany
| | - E Lapeira
- MGEP Mondragon GoiEskola Politeknikoa, Mechanical and Industrial Manufacturing Department, Mondragon, Spain
| | | | - J -C Legros
- MRC, Université libre de Bruxelles, Av. F.D. Roosevelt, 50, CP165/62, 1050, Brussels, Belgium
| | - I Lizarraga
- MGEP Mondragon GoiEskola Politeknikoa, Mechanical and Industrial Manufacturing Department, Mondragon, Spain
| | - T Lyubimova
- Institute of Continuous Media Mechanics UB RAS, 614013, Perm, Russia
| | - S Mazzoni
- European Space Agency (ESA), ESTEC, Noordwijk, The Netherlands
- Dipartimento di Fisica, Università degli Studi di Milano, I-20133, Milano, Italy
| | - N Melville
- European Space Agency (ESA), ESTEC, Noordwijk, The Netherlands
| | - A Mialdun
- MRC, Université libre de Bruxelles, Av. F.D. Roosevelt, 50, CP165/62, 1050, Brussels, Belgium
| | - O Minster
- European Space Agency (ESA), ESTEC, Noordwijk, The Netherlands
| | - F Montel
- Laboratoire des Fluides Complexes et leurs Réservoirs - IPRA, UMR5150, E2S-Univ Pau & Pays Adour / CNRS / TOTAL, 64000, Pau, France
| | - F J Molster
- European Space Agency (ESA), ESTEC, Noordwijk, The Netherlands
| | - J M Ortiz de Zárate
- Departamento de Estructura de la Materia, Facultad de Fisica, Universidad Complutense, Plaza de las Ciencias 1, 28040, Madrid, Spain
| | - J Rodríguez
- E-USOC. ETSIAE, Universidad Politécnica de Madrid, Madrid, Spain
| | - B Rousseau
- Laboratoire de Chimie-Physique, UMR 8000 CNRS, Université Paris-Sud, Orsay, France
| | - X Ruiz
- Centre National d'Etudes Spatiales (CNES), 2, Place Maurice Quentin, 75001, Paris, France
| | - I I Ryzhkov
- Institute of Computational Modelling SB RAS, 660036, Akademgorodok, Krasnoyarsk, Russia
| | - M Schraml
- Physikalisches Institut, Universität Bayreuth, D-95440, Bayreuth, Germany
| | - V Shevtsova
- MRC, Université libre de Bruxelles, Av. F.D. Roosevelt, 50, CP165/62, 1050, Brussels, Belgium
| | - C J Takacs
- Department of Physics, University of California at Santa Barbara, 93106, Santa Barbara, CA, USA
| | - T Triller
- Physikalisches Institut, Universität Bayreuth, D-95440, Bayreuth, Germany
| | - S Van Vaerenbergh
- MRC, Université libre de Bruxelles, Av. F.D. Roosevelt, 50, CP165/62, 1050, Brussels, Belgium
| | - A Vailati
- Dipartimento di Fisica, Università degli Studi di Milano, I-20133, Milano, Italy
| | - A Verga
- European Space Agency (ESA), ESTEC, Noordwijk, The Netherlands
| | - R Vermorel
- Laboratoire des Fluides Complexes et leurs Réservoirs - IPRA, UMR5150, E2S-Univ Pau & Pays Adour / CNRS / TOTAL, 64000, Pau, France
| | - V Vesovic
- Department of Earth Science and Engineering, Imperial College London, London, UK
| | - V Yasnou
- MRC, Université libre de Bruxelles, Av. F.D. Roosevelt, 50, CP165/62, 1050, Brussels, Belgium
| | - S Xu
- Key Laboratory of Microgravity, Institute of Mechanics, Chinese Academy of Science, Beijing, China
| | - D Zapf
- Physikalisches Institut, Universität Bayreuth, D-95440, Bayreuth, Germany
| | - K Zhang
- State Key Laboratory of Enhanced Oil Recovery (Research Institute of Petroleum Exploration & Development), CNPC, Beijing, China
| |
Collapse
|
11
|
Kern M, Buia A, Tonus C, Weigel TF, Dittmar R, Hanisch E, Zapf D. [Psychological stressors, resources and well-being of surgeons in Germany : A cross-sectional study]. Chirurg 2019; 90:576-584. [PMID: 30610261 DOI: 10.1007/s00104-018-0780-5] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
BACKGROUND Psychological stress at work is associated with detrimental and health-impairing consequences for employees. OBJECTIVE In this study major stress factors and the resource job control at the workplace of surgeons and facets of mental health were examined and compared to benchmark results of a large reference sample. METHOD Data were collected by a representative online survey among surgeons throughout Germany who were contacted via the Professional Association of German Surgeons. In total 643 surgeons from different organizations and different disciplines completed the questionnaire that was developed using well-validated instruments. RESULTS Time pressure was the most meaningful stress factor for surgeons. Moreover, the results for medical assistants showed adverse stress combinations of high goal uncertainty and low job control as well as high emotional exhaustion and low job satisfaction. In addition, the results indicated that surgeons in single and group practices as well as in outpatient healthcare centers have less stressors and more job resources. CONCLUSION The survey results suggest high levels of burnout risk for German surgeons, especially among medical assistants and medical specialists from large hospitals. In order to maintain a high quality in the surgical disciplines, a concerted effort by all players in the healthcare system is necessary.
Collapse
Affiliation(s)
- M Kern
- Abteilung Arbeits- und Organisationspsychologie, Goethe-Universität Frankfurt, PEG, Theodor-W.-Adorno-Platz 6, 63, 60629, Frankfurt am Main, Deutschland.
| | - A Buia
- Klinik für Allgemein‑, Viszeral- und Thoraxchirurgie, Asklepios Klinik Langen, Langen, Deutschland
| | - C Tonus
- Klinik für Allgemein- und Viszeralchirurgie, Asklepios Klinik St. Georg, Hamburg, Deutschland
| | - T F Weigel
- Klinik für Allgemein- und Viszeralchirurgie, Heilig-Geist-Hospital, Bingen, Deutschland
| | - R Dittmar
- Berufsverband der Deutschen Chirurgen, Berlin, Deutschland
| | - E Hanisch
- Klinik für Allgemein‑, Viszeral- und Thoraxchirurgie, Asklepios Klinik Langen, Langen, Deutschland
| | - D Zapf
- Abteilung Arbeits- und Organisationspsychologie, Goethe-Universität Frankfurt, PEG, Theodor-W.-Adorno-Platz 6, 63, 60629, Frankfurt am Main, Deutschland
| |
Collapse
|
12
|
Orlishausen M, Butzhammer L, Schlotbohm D, Zapf D, Köhler W. Particle accumulation and depletion in a microfluidic Marangoni flow. Soft Matter 2017; 13:7053-7060. [PMID: 28848950 DOI: 10.1039/c7sm00954b] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Thermosolutal and thermocapillary Marangoni convection at a liquid-gas interface in a microchannel structure of approximately 100 × 90 μm2 cross section creates a localized vortex that acts as a trap for micrometer and sub-micrometer sized tracer particles. Next to the vortex, depleted volumes appear that are entirely cleared of particles. This particle redistribution is caused by collisions of the tracers with the meniscus, which push the particles back onto the critical streamline with one particle radius distance to the meniscus. The streamlines between the meniscus and the critical streamline feed the depleted regions. Since the critical streamline depends on the particle radius, the effect leads to a particle fractionation according to their size. Diffusion allows only small particles to escape from the trap. Larger particles are permanently confined and their diffusion is rectified after every revolution at the meniscus, which produces a ratchet effect and increases the particle localization within the vortex.
Collapse
Affiliation(s)
- M Orlishausen
- Physikalisches Institut, Universität Bayreuth, D-95440 Bayreuth, Germany.
| | | | | | | | | |
Collapse
|
13
|
Ranjbar M, Brinkmann MP, Zapf D, Miura Y, Rudolf M, Grisanti S. Fc Receptor Inhibition Reduces Susceptibility to Oxidative Stress in Human RPE Cells Treated with Bevacizumab, but not Aflibercept. Cell Physiol Biochem 2016; 38:737-47. [PMID: 26871551 DOI: 10.1159/000443030] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/04/2016] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND/AIMS VEGF-A is induced by oxidative stress, and functions as a survival factor for various cell types, including retinal pigment epithelial (RPE) cells. Anti-vascular endothelial growth factor (VEGF) drugs like aflibercept and bevacizumab have shown to be most effective in treating neovascular age-related macular degeneration (AMD), however uptake of the drugs might lead to interference with cell physiology. Herein, we evaluated the significance of the Fc receptor (FcR) within this context and moreover explored the impact of VEGF inhibition under normal conditions as well as under oxidative stress, in terms of potential adverse effects. METHODS ARPE-19 (human RPE) cells were treated with aflibercept and bevacizumab in presence or absence of H2O2 as oxidative stress stimulus. After 24h cells were evaluated for drug uptake, VEGF-A expression and secretion, levels of intracellular reactive oxygen species (ROS) as well as cell proliferation. Experiments were repeated with cells being pre-incubated with an FcR inhibitor prior to drug application. RESULTS Both drugs inhibited extracellular levels of VEGF-A and were taken up into the RPE, resulting in significantly reduced intracellular levels of VEGF-A. When oxidative stress was applied, intracellular ROS levels in cells treated with both drugs rose, and cell proliferation was reduced. Prior incubation with the FcR inhibitor lessened the uptake of bevacizumab, but not aflibercept into RPE cells, and simultaneously enhanced cell survival under oxidative stress conditions. CONCLUSIONS Our results indicate that uptake and accumulation of aflibercept and bevacizumab within RPE cells affect the intracellular VEGF-A metabolism negatively, leading to a biologically relevant reduced cell survival under oxidative stress. The FcR plays a substantial role in the uptake of bevacizumab, but not aflibercept, which allows an enhanced RPE cell survival through FcR blockage in an environment dominated by oxidative stress, as clinically significant for various inflammatory retinal disorders.
Collapse
Affiliation(s)
- Mahdy Ranjbar
- Department of Ophthalmology, University of Lx00FC;beck, Lx00FC;beck, Germany
| | | | | | | | | | | |
Collapse
|
14
|
Escartin J, Ceja L, Navarro J, Zapf D. Modeling workplace bullying using catastrophe theory. Nonlinear Dynamics Psychol Life Sci 2013; 17:493-515. [PMID: 24011118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
Workplace bullying is defined as negative behaviors directed at organizational members or their work context that occur regularly and repeatedly over a period of time. Employees' perceptions of psychosocial safety climate, workplace bullying victimization, and workplace bullying perpetration were assessed within a sample of nearly 5,000 workers. Linear and nonlinear approaches were applied in order to model both continuous and sudden changes in workplace bullying. More specifically, the present study examines whether a nonlinear dynamical systems model (i.e., a cusp catastrophe model) is superior to the linear combination of variables for predicting the effect of psychosocial safety climate and workplace bullying victimization on workplace bullying perpetration. According to the AICc, and BIC indices, the linear regression model fits the data better than the cusp catastrophe model. The study concludes that some phenomena, especially unhealthy behaviors at work (like workplace bullying), may be better studied using linear approaches as opposed to nonlinear dynamical systems models. This can be explained through the healthy variability hypothesis, which argues that positive organizational behavior is likely to present nonlinear behavior, while a decrease in such variability may indicate the occurrence of negative behaviors at work.
Collapse
|
15
|
Johnson SJ, Holdsworth L, Hoel H, Zapf D. Customer stressors in service organizations: The impact of age on stress management and burnout. European Journal of Work and Organizational Psychology 2013. [DOI: 10.1080/1359432x.2013.772581] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
16
|
Dormann C, Zapf D. Social support, social stressors at work, and depressive symptoms: testing for main and moderating effects with structural equations in a three-wave longitudinal study. J Appl Psychol 1999; 84:874-84. [PMID: 10639907 DOI: 10.1037/0021-9010.84.6.874] [Citation(s) in RCA: 179] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Abstract
This study investigated the moderating effects of social support by supervisors and colleagues relative to social stressors at work and depressive symptoms using a structural equations approach in a 3-wave longitudinal study over 1 year. The analyses were based on a randomly drawn sample (N = 543) of citizens in the area around Dresden in the former East Germany. LISREL analysis with latent moderating effects revealed a moderating effect for supervisor support. This applied only if the time lag was 8 months, but not for longer or shorter lags. Under low-support conditions depressive symptoms were increased by social stressors, whereas, contrary to expectations, social stressors reduced subsequent depressive symptoms under high-support conditions. No moderating effect for colleague support was found. Several mechanisms are discussed that may explain the results.
Collapse
Affiliation(s)
- C Dormann
- Department of Psychology, University of Giessen, Germany.
| | | |
Collapse
|
17
|
Zapf D, Dormann C, Frese M. Longitudinal studies in organizational stress research: a review of the literature with reference to methodological issues. J Occup Health Psychol 1998. [PMID: 9547043 DOI: 10.1037//1076-8998.1.2.145] [Citation(s) in RCA: 112] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Demonstrating causal relationships has been of particular importance in organizational stress research. Longitudinal studies are typically suggested to overcome problems of reversed causation and third variables (e.g., social desirability and negative affectivity). This article reviews the empirical longitudinal literature and discusses designs and statistical methods used in these studies. Forty-three longitudinal field reports on organizational stress were identified. Most of the investigations used a 2-wave panel design and a hierarchical multiple regression approach. Six studies with 3 and more waves were found. About 50% of the studies analyzed potential strain-stressor (reversed causation) relationships. In about 33% of the studies there was some evidence of reverse causation. The power of longitudinal studies to rule out third variable explanations was not realized in many studies. Procedures of how to analyze longitudinal data are suggested.
Collapse
Affiliation(s)
- D Zapf
- Faculty of Social Sciences, University of Konstanz, Germany.
| | | | | |
Collapse
|
18
|
Zapf D, Dormann C, Frese M. Longitudinal studies in organizational stress research: a review of the literature with reference to methodological issues. J Occup Health Psychol 1996; 1:145-69. [PMID: 9547043 DOI: 10.1037/1076-8998.1.2.145] [Citation(s) in RCA: 690] [Impact Index Per Article: 24.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Demonstrating causal relationships has been of particular importance in organizational stress research. Longitudinal studies are typically suggested to overcome problems of reversed causation and third variables (e.g., social desirability and negative affectivity). This article reviews the empirical longitudinal literature and discusses designs and statistical methods used in these studies. Forty-three longitudinal field reports on organizational stress were identified. Most of the investigations used a 2-wave panel design and a hierarchical multiple regression approach. Six studies with 3 and more waves were found. About 50% of the studies analyzed potential strain-stressor (reversed causation) relationships. In about 33% of the studies there was some evidence of reverse causation. The power of longitudinal studies to rule out third variable explanations was not realized in many studies. Procedures of how to analyze longitudinal data are suggested.
Collapse
Affiliation(s)
- D Zapf
- Faculty of Social Sciences, University of Konstanz, Germany.
| | | | | |
Collapse
|